A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients

2024-9-13

Untangling the loops of <i>STAG2</i> mutations in myelodysplastic syndrome

2024-9-12

Outcomes of non-COVID-19 critically ill patients with hematologic malignancies a 10-year single-center retrospective analysis

2024-9-12

The prognostic effect of blast count in <i>TP53</i> mutant myeloid neoplasms –the Minnesota experience

2024-9-10

Clinical characteristics and outcomes of Brazilian patients with duodenal-type follicular lymphoma: a multicenter retrospective study

2024-9-10

Eligibility for clinical trials in diffuse large B-cell lymphoma: are we sweating the small stuff?

2024-9-5

The impact of initial tumor bulk in DLBCL treated with DA-EPOCH-R <i>vs.</i> R-CHOP: a secondary analysis of alliance/CALGB 50303

2024-9-5

Homoharringtonine sensitized resistant acute myeloid leukemia cells to venetoclax-induced apoptosis

2024-9-5

Chronic lymphocytic leukemia with <i>MDM2</i> amplification as an alternative pathway to TP53 dysfunction

2024-9-4

Response to intensive induction chemotherapy after failure of frontline azacitidine and venetoclax in acute myeloid leukemia

2024-9-4

Advanced stage classic Hodgkin lymphoma (cHL): biology, clinical features, therapeutic approach, and management at relapse

2024-9-3

Analysis of the clinical features and outcomes of relapsed intravascular large B-cell lymphoma: a single center study

2024-9-3

Aplastic anemia in association with multiple myeloma: clinical and pathophysiological insights

2024-9-3

Nivolumab for CNS relapsed refractory primary mediastinal B-cell lymphoma: case report and review of the literature

2024-9-3

The impact of trial inclusion criteria on outcomes in DLBCL patients treated with R-CHOP in the first line: a Danish nationwide study

2024-9-3

Routine follow-up practices in patients with lymphoma: a nationwide survey by the Italian lymphoma foundation

2024-9-3

Advances in the understanding of molecular genetics and therapy of Richter transformation in chronic lymphocytic leukemia

2024-9-2

RUNX1 expression is regulated by a super-enhancer and is a therapeutic target in adult T-cell leukemia/lymphoma

2024-9-1

Predicting relapse in acute lymphoblastic leukemia

2024-8-31

<i>IKZF1</i> in acute lymphoblastic leukemia: the rise before the fall?

2024-8-29

The diagnosis of Burkitt lymphoma: how do pathologists apply criteria in daily practice?

2024-8-29

Concurrent myelodysplastic malignancies and plasma cell neoplasms; a clinicopathological study with prognostic implications

2024-8-23

Reduced prognostic value of beta-2-microglobulin for time to first treatment in CLL patients with compromised kidney function

2024-8-21

The NOTCH1 and miR-34a signaling network is affected by <i>TP53</i> alterations in CLL

2024-8-19

Sun protection behaviors among adult survivors receiving hematopoietic cell transplantation: a cross-sectional survey of a single institution in Japan

2024-8-18

Successful treatment of acquired von Willebrand syndrome secondary to low-grade CLL with rituximab and venetoclax

2024-8-18

Risk factors and development of a predictive score model for tumor lysis syndrome in childhood leukemia: a 10-year experience from a single tertiary hospital in Thailand

2024-8-18

The characterization and the impact of CSF pleocytosis during blinatumomab therapy for adult acute lymphoblastic leukemia

2024-8-18

New therapies for angioimmunoblastic T-cell lymphoma: a comprehensive review and analysis

2024-8-15

Long-term exposure and response to azacitidine for post-hematopoietic stem cell transplantation relapse of early T-cell precursor acute lymphoblastic leukemia: a case report and review of the literature

2024-8-14

Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG)

2024-8-14

Arsenic trioxide-induced peripheral neuropathy: prospective clinical and neurophysiological evaluation in a cohort of patients with acute promyelocytic leukemia

2024-8-13

CAR T-cells in very elderly (≥80 years) lymphoma patients: a DESCAR-T analysis

2024-8-13

Relationships, marriage, and partner abandonment among Hodgkin lymphoma survivors treated in nine EORTC-GELA Lymphoma Group trials

2024-8-12

Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study

2024-8-11

The clinical implications of <i>BCOR</i> mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study

2024-8-10

Prospects for liquid biopsy approaches in lymphomas

2024-8-10

Pediatric therapy-related hematologic neoplasms show enrichment for <i>KMT2A</i> rearrangement and lymphoblastic phenotype

2024-8-8

Association between skeletal muscle mass and treatment response in patients with diffuse large B-cell lymphoma

2024-8-2

Venetoclax-based induction therapy for primary plasma cell leukemia with high BCL-2 expression

2024-8-1

Post-ASCT consolidation with elotuzumab, lenalidomide, and dexamethasone or elotuzumab, pomalidomide, and dexamethasone in high-risk and ultra-high-risk multiple myeloma: a retrospective single-center study

2024-7-31

PTCy-ATG mutually exclusive or additive? Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia

2024-7-31

Sarcopenia is a prognostic factor in lymphoma patients: a systematic review and meta-analysis

2024-7-31

National study reveals gram negative bacteremia on contemporary pediatric AML protocol

2024-7-30

A case report of solitary presentations of large B-cell lymphoma of immune-privileged sites (IP-LBCL) in the testis, vitreous body, and skin

2024-7-30

The utility of next generation sequencing-based minimal residual disease monitoring in a post-myeloproliferative neoplasm acute myeloid leukemia patient: a case report

2024-7-29

Trends in location of death for individuals with acute myeloid leukemia in the United States

2024-7-27

Clinicopathologic characteristics of <i>de novo NF1</i> -mutated acute myeloid leukemia

2024-7-27

A case of posterior reversible encephalopathy syndrome (PRES) in an elderly patient with advanced classical Hodgkin Lymphoma during frontline treatment with brentuximab vedotin plus AVD

2024-7-27

Long-term survival outcome of childhood acute myeloid leukemia: a 43-year experience in Thailand, a resource-limited country

2024-7-26